389470 — Inventage Lab Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMid CapSucker Stock

Annual cashflow statement for Inventage Lab, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	PROSPECTUS	ARS/A	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-9,271	-10,595	-26,994	-16,997	-15,911
Depreciation
Amortisation
Non-Cash Items	916	1,096	11,602	-1,412	-10,229
Unusual Items
Other Non-Cash Items
Changes in Working Capital	-2,002	1,886	1,071	812	-1,789
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Cash from Operating Activities	-8,513	-5,189	-11,711	-13,764	-20,308
Capital Expenditures	-2,497	-1,980	-7,141	-4,220	-7,264
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	3,152	-8,594	5,627	-20,564	14,061
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	655	-10,574	-1,514	-24,784	6,797
Financing Cash Flow Items	0	36.9	78	81.6	-1,269
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	15,184	12,288	15,926	37,331	10,714
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	7,326	-3,475	2,701	-1,217	-2,797